- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2024
- 159 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- April 2023
- 147 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- November 2023
- 171 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
Procainamide is a medication used to treat irregular heartbeats and other cardiac arrhythmias. It is a type of antiarrhythmic drug, and is classified as a Class Ia antiarrhythmic agent. It works by blocking sodium channels in the heart, which helps to regulate the heart rate. It is also used to treat ventricular tachycardia, a condition in which the heart beats too quickly.
Procainamide is available in both oral and intravenous forms. It is typically used in combination with other medications, such as beta blockers and diuretics. It is generally well tolerated, but can cause side effects such as nausea, dizziness, and headache.
Procainamide is a commonly used medication in the cardiovascular drug market. It is used to treat a variety of cardiac arrhythmias, and is generally well tolerated. It is available in both oral and intravenous forms, and is often used in combination with other medications.
Some companies that produce procainamide include Pfizer, Merck, and Sanofi. Show Less Read more